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The objective of this study was to formulate and evaluate 
gastric floating dosage forms of hollow microspheres for 
controlled delivery of dextromethorphan hydrobromide (DBM). 
Hollow microspheres were prepared by emulsion polymerization 
method using natural polymer gelatin as release retardant and 
coating agent. Hollow microspheres were characterized by FT-IR, 
DSC, SEM, and micromeritic properties. FT-IR and DSC studies 
showed no chemical interaction between the drug and polymers. 
Hollow microspheres were evaluated for percentage yield, 
encapsulation efficiency and in vitro release studies. The 
obtained angle of repose, % Carr’s index, Hausner ratio, and 
tapped density values were within the limits indicating good flow 
properties. The surface morphology revealed that microspheres 
were spherical with minute pores and invert dents on the 
surface. Among all the formulations, F-3 of hollow microspheres 
showed highest drug release of 79.69±0.12% at the end of 12h 
which was considered as the best formulation. The release data 
was fitted to various mathematical models such as, Higuchi, 
Korsmeyer-Peppas, First-order, and Zero order to evaluate the 
release kinetics and mechanism of the drug release. The release 
kinetics indicated that drug release followed non-fickian diffusion 
mechanism. Results of the stability studies showed that there 
were no significant changes in the drug content and physical 
appearance.  
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INTRODUCTION 
The design of oral controlled drug 
delivery systems (DDS) primarily aimed to 
achieve more predictable and increased 
bioavailability. (Garima et al., 2003). Now-a-
days most of the pharmaceutical scientists are 
involved in developing the ideal DDS. This 
ideal system should have advantage of single 
dose for the whole duration of treatment and it 
should deliver the active drug directly at the 
specific site. Controlled release implies the 
predictability and reproducibility to control the 
drug release, drug concentration in target tissue 
and optimization of the therapeutic effect of a 
drug by controlling its release in the body with 
lower and less frequent dose. (Mathiowitz 1999; 
Shivakumar et al., 2004). 
Floating microspheres are gastroreten-
tive drug delivery system based on non-
effervescent approach. They are low density 
systems, which have sufficient buoyancy to 
float over gastric contents and remain in 
stomach for prolonged period of time. When 
microspheres come in contact with gastric fluid 
the gel formers, polysaccharides and polymers 
hydrate to form a colloidal gel barrier that 
controls the rate of fluid penetration into the 
device and consequent drug release. As the 
exterior surface of the dosage form dissolves, 
the gel layer is maintained by the hydration of 
the adjacent hydro-colloidal layer. The air 
trapped by swollen polymer lowers the density 
and confers buoyancy to the microspheres. 
(Deshpande et al., 1997; Mathiowitz et al., 1987). 
Dextromethorphan hydrobromide, a 
centrally acting non-opioid antitussive drug is 
an effective and safe for the control of cough & 
asthma in patients. It is readily absorbed from 
the upper GIT. Dose is 10-30mg daily in divi-
ded dose. Due to its short biological half-life of 
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1.4-3.9h, it requires multiple dosing (2-3 times a 
day). Multiple dosing leads to fluctuation in the 
drug blood level and often dose related adverse 
effects. Multiple dosing also often results in 
poor compliance and inefficient therapy. To 
increase therapeutic efficacy, reduce frequency 
of administration and for better patient 
compliance twice daily controlled release 
dextromethorphan hydrobromide gastric 
floating dosage forms are prepared to prolong 
the residence time in absorption region for 
desired period of time. 
Dextromethorphan hydrobromide 
belongs to the class II of biopharmaceutics 
classification system (BCS), exhibits low 
solubility and high permeability. Hence, 
enhanced gastric retention time of 
dextromethorphan hydrobromide controlled 
release dosage form will increase its absorption. 
Therefore, dextromethorphan hydrobromide 
was selected as a suitable drug for the design  
of a gastric floating drug delivery system 
(GDDS) with a view to improve its oral 
bioavailability. 
 
MATERIAL AND METHODS 
Dextromethorphan Hydrobromide was 
purchased from Divis Laboratories Pvt Ltd, 
Hyderabad. Gelatin was procured from Loba 
Chemie Pvt Ltd, Mumbai. Liquid paraffin, Span 
80, Tween 80, Glutaraldehyde were purchased 
from Sigma Aldrich, Bangalore. All other 





This method is widely used in 
microencapsulation process. The microspheres 
are prepared by emulsion polymerization 
method. The polymer gelatin is dissolved in 
water with little heating maintains the solution 
at 60°C. Drug is dispersed in polymer solution 
with continuous stirring for about 3min. Then 
take 10mL of liquid paraffin and add 
emulsifying agent (span 80 or tween 80) along 
with 1% glutaraldehyde which was a cross 
linking agent. The aqueous phase was 
emulsified into the oily phase by stirring the 
system with constant stirring at 1000rpm using 
mechanical stirrer. Stirring was continued for 
3h until the aqueous phase was completely 
removed by evaporation. The light oil was 
decanted and microspheres were collected by 
filtering through Whatmann filter paper, dried 
in an oven at 40ºC for 2h and stored in a 
desiccator at room temperature. Composition 
of hollow microspheres is given in table I. 
 
Preformulation studies 
The prepared formulations were 
characterized by Fourier Transform Infra-red 
Spectroscopy, Differential Scanning 
Calorimetry, Scanning Electron Microscopy, 
and X-ray Diffraction analysis. 
 
 FT-IR 
The FTIR (Fourier Transform Infra-Red 
Spectroscopy) spectra of the prepared formula-
tions  were  recorded  over  the  range   of  400- 
Table I. Formulation chart of DBM hollow microspheres 
 
Sl No Ingredients 
Formulations 
F1 F2 F3 F4 F5 
1 Dextromethorphan hydrobromide (mg) 45 45 45 45 45 
2 Gelatin (mg) 100 150 200 250 300 
3 Liquid paraffin (mL) 10 10 10 10 10 
4 Span 80 (mL) 2 4 _ _ 2 
5 Tween 80 (mL) _ _ 2 4 2 
6 Glutaraldehyde (%) 1 1 1 1 1 
7 Distilled water (mL) 5 5 5 5 5 
 
Preformulation studies 
The prepared formulations were characterized by Fourier Transform Infra-red Spectroscopy, Differential 
Scanning Calorimetry, Scanning Electron Microscopy, and X-ray Diffraction analysis. 
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4000cm-1 by KBr pellet method using FTIR 
spectrophotometer. The compatibility between 
the drug and the polymers were compared by 
FT-IR spectra.  
 
DSC 
Differential scanning calorimetry (DSC) 
was performed on pure sample of drug and its 
formulation using DSC-Q200 apparatus. 
Calorimetric measurements were made with 
empty cell (high purity alpha alumina discs) as 
the reference. The dynamic scans were taken in 
nitrogen atmosphere at the heating rate of 10°C 




Scanning Electron Microscopy (SEM) 
The surface morphology of formulations was 
determined using a scanning electron 
microscope. Samples were mounted on 
aluminum mount, using double sided adhesive 
tape and sputtered by gold under vacuum and 
were scanned at an accelerating voltage of 
15KV before observation. 
 
Angle of repose (Aulton, 1996; Ansel et 
al., 2000; Brahmankar and Jaiswal 1998) 
Angle of repose is the maximum angle 
possible between the surface of a pile and the 
horizontal plane. Angle of repose (θ) was 
assessed to know the flowability of 
microspheres, by a fixed funnel method using 
the formula 
Tan (θ) = h/r 
Where 'h' is height of heap and 'r' is 
radius of the heap. Angle of repose represents 
whether the given sample was free flowing or 
not.  
 
Compressibility index  
Compressibility index was measured for 
the property of powder to be compressed, as 
such they are measured for relative importance 
of inter particulate interactions. Compressibility 
index and was calculated by the following 
equation, (Rama et al., 1998) 
Compressibility index = 
[(Dt – Db)] 
Dt x 100 
Where, Dt= tapped density; Db= bulk density; 
 
Drug content 
Formulation equivalent to 45 mg of 
Dextromethorphan hydrobromide was taken and 
transferred to 100 ml volumetric flask, dissolved and 
diluted with pH 1.2 HCl buffer. The absorbance of 
the resulting solution was measured at 279nm using 
a UV spectrophotometer after filtration through 
Whatmann filter paper. 
The drug content was calculated using the 
following equation: 
% drug content = 
con( )x dilution factor 
X 100 
label claim (mg) 
 
Percentage yield (% yield)  
The yield was determined by weighing 
the hollow microspheres and then finding out 
the percentage yield with respect to the weight 
of the input materials, i.e., weight of drug and 
polymers used. The formula for calculation of 
% yield is as follows; 
 
Drug entrapment efficiency 
Percentage drug entrapment was determined 
by UV spectrophotometric method. Drug was 
extracted from the microballoons using 1N HCl and 
the absorbance was measured using UV-visible 
spectrophotometer at 279nm. The drug entrapment 
efficiency (DEE) was calculated by the equation,  
DEE = (Pc / Tc) X 100 
Pc is practical content, Tc is the theoretical 
content.  
 
Particle size analysis 
The particle sizes of drug loaded 
formulations were measured by an optical 
microscope fitted with an ocular and stage 
micrometer and particle size distribution was 
calculated. About 100 microspheres were 
selected randomly and their size was 
determined. 
Xg=10 x [(ni x log Xi) / N] 
Xg is geometric mean diameter, ni is 
number of particle in range, Xi is the midpoint 
of range and N is the total number of particles.  
 
Percentage of moisture loss 
The dextromethorphan hydrobromide 
loaded hollow microspheres were evaluated for 
percentage of moisture loss which sharing an 
idea about its hydrophilic nature. The micros-
pheres weighed initially and kept in desiccators 
containing calcium chloride at 37°C for 24 h. 
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When no further change in weight of sample 
was observed, the final weight was noted down. 
% of moisture 
loss = 
Initial weight - Final weight 
X 100 
Initial weight 
Floating lag time and in vitro buoyancy 
Floating lag time is the time taken by the 
tablet or hollow microspheres to emerge onto 
the surface of the dissolution medium after 
adding to simulated gastric fluid without pepsin 
(500 ml o pH 1.2 HCl buffer). The time taken 
by the tablet or hollow microspheres to rise to 
the surface of the dissolution media and time 
taken for it to sink was noted, the difference of 
which gives the duration of buoyancy. 
 
In vitro release studies (Ninam,et al., 2008) 
In vitro drug release of dextromethorphan 
hydrobromide was evaluated in triplicate at 
37±0.5°C using a USP XXIV dissolution 
testing apparatus type 2 (paddle method) at a 
rotation speed of 50rpm in 250mL pH 1.2 HCl 
buffer for 12h. At regular time intervals, 10mL 
of the dissolution medium were withdrawn, 
replaced with an equivalent volume of fresh 
dissolution fluid and analyzed for the drug 
content using a UV-Vis spectrophotometer at 
279nm. 
 
Mathematical model fitting 
The in vitro release data were fitted into 
various mathematical models using PCP. 
Disso-V2.08 software to know which 
mathematical model will best fit the obtained 
release profile. The parameters like ‘n’ the 
diffusion exponent and ’R’ the regression co-
efficient were determined to know the release 
mechanisms. The model with the highest 
correlation coefficient values or determination 
coefficient (R2) was considered as the best fit 
model. If the value of ‘n’ determined from 
Korsmeyer-Peppas equation was below 0.45, it 
indicate that the drug release from the 
formulation follows fickian diffusion, if ‘n’ 
value was between 0.5-0.85, it indicate Non-
Fickian diffusion or anomalous mechanism 
(relaxation controlled) and if ‘n’ value was 
above 0.89, it indicate super case II transport. 
 
Stability studies 
The objective of stability studies is to 
predict the shelf life of a product by 
accelerating the rate of decomposition, 
preferably by increasing the temperature and 
relative humidity (RH) conditions. Optimized 
formulation was selected and packed in a screw 
capped bottle and studies were carried out for 
90 days by keeping at 40+2ºC and 75+5 RH. 
Samples were withdrawn on 30th day, 
60th day and 90th day and were analyzed for 
drug content spectrophotometrically at 279nm 
as per ICH Q1A(R2) guidelines. 
 
RESULTS AND DISCUSSION 
FT-IR 
The pellets of drug and potassium 
bromide were prepared by compressing the 
powders at 20psi for 1min on KBr‐press and 
the spectra were scanned in the wave number 
range of 4000-450cm-1. FT-IR study was carried 
on pure drug and final formulations of hollow 
microspheres. Characteristic peaks were 
observed at 3075cm-1corresponding to S-H 
stretch, 793-626cm-1 corresponding to C-S 
stretch, 1338-1316cm-1 corresponding to C-N 
stretch, 1634cm-1 (C=O stretch), 1286-1223cm-
1 corresponding to C-O-C stretching and at 
918cm-1 corresponding to out of plane bending. 
In terms of final formulation peaks were 
obtained at 3407cm-1 corresponding to N-H 
asymmetric stretching, 2924cm-1 corresponding 
to C-H stretching, 1638cm-1 corresponding to 
C=O stretching, 1458cm-1 corresponding to C-
H bending, 1365cm-1 corresponding to OH in 
plane bending, 1259-1229cm-1 corresponding to 
C-O-C stretching, 1216-1063cm-1 corresponding 
to C-N stretching, 750cm-1 corresponding to C-
S stretching. All the formulation peaks when 
compared to pure drug were similar and this 
implied that there were there no incompatibility 
issues between the drug and the excipients. 
 
SEM 
The scanning electron microscopy 
(SEM) study was carried to identify the surface 
morphology of the hollow microspheres which 
were presented in figures 1a & 1b. SEM 
photographs showed that the drug loaded 
hollow microspheres were spherical in nature 
(mean size of around 285.9µm), having a 
smooth surface with inward dents and 
shrinkage due to the collapse of the wall of the 
microspheres.  SEM photograph revealed the
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absence of drug particles on the surface of 
microspheres indicating the uniform 
distribution of the drug in the walls of the 
microspheres. SEM photographs also indicated 
the presence of minute pores on the surface of 
the microspheres. It might be due to rapid 
diffusion of the solvent from the walls of the 
microspheres and there is a possibility of 
rupture of microsphere walls.  
 
Bulk density 
Bulk density may influence capsule 
filling, dissolution and other properties. The 
Bulk density refers to a measure used to 
describe a packing of microspheres. Bulk 
density largely depends on particle shape. As 
particles become more spherical in shape bulk 
density is increased. In addition microspheres 
size increases, bulk density decreases. Here, the 
bulk density of dextromethorphan hydro-
bromide hollow microspheres formulations F1-
F5 are determined and given in table II. 
 
Tapped density 
Tapped density largely depends on 
particle shape. As particles become more 
spherical in shape tapped density is increased. 
In addition microspheres size increases, tapped 
density decreases. Here the tapped density of 
Dextromethorphan hydrobromide micros-
pheres formulations F1-F5 are determined and 
given in table II. 
 
Angle of repose 
The angle of repose for 
Dextromethorphan hydrobromide hollow 
microspheres shows good flow characteristics 
that lead to the uniform filling of dosage form 
in capsules. It was done as per the procedure 




Figure 1. SEM photograph of formulation F3 
 













F1 0.11±2.01 0.13±1.03 1.12±1.11 10.4±2.21 31.34°±1.01 
F2 0.11±1.72 0.12±1.32 1.10±1.28 9.32±1.98 30.00°±1.11 
F3 0.12±1.89 0.14±1.49 1.18±1.39 9.5±2.54 35.14°±1.92 
F4 0.07±2.63 0.08±1.25 1.13±1.09 11.4±1.89 36.42°±1.78 
F5 0.08±1.18 0.09±1.56 1.10±1.35 9.09±2.11 38.27°±1.80 
 
*Mean ± SD, n=3 
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Carr’s index 
The measurement of free flowing 
granules can also be done by compressibility 
with the tapped and untapped values. The 
compressibility index of Dextromethorphan 
hydrobromide hollow microspheres is 
determined and given in table II and it is found 
to have good flow characteristics. 
The Hausner’s ratio of dextromethor-
phan hydrobromide hollow microspheres was 
calculated and it shows good flow charac-
teristics. The values are given in table II 
 
Particle size analysis 
All the hollow microspheres were 
evaluated with respect to their size and shape 
using optical microscope fitted with an ocular 
micrometer and a stage micrometer. The 
particle diameters of more than 50 
microspheres were measured randomly by 
optical microscope. The microspheres were 
uniform in size with a mean size range of 
57.75±3.5 to 94.25±7.0µm which fall in the 
arbitrary particle size range of 5-50mm. 
Influence of surfactants was clearly observed in 
terms of particle size. As the concentration of 
surfactants increased particle size decreased. 
Comparing between the surfactants, Tween 80 
showed good particle size than span 80. The 
particle size ranges are shown in table III. 
 
Percentage Yield 
Percentage yield of the formulations was 
found in the range 71.3-88.8%, and among the 
five formulations the % yield of formulation F3 
is 88.8%. 


















F1 67.16±3.0 79.5% 94.29±1.32 78.16±1.12 3.57±0.02 80.7±4.8 
F2 57.75±3.5 81.7% 95.87±1.28 88.11±1.38 1.69±0.12 83.4±2.1 
F3 94.25±7.0 88.8% 96.10±1.40 90.31±1.59 1.63±0.29 94.2±3.2 
F4 87.65 ± 4.5 71.3% 89.06±1.59 68.27±1.62 3.97±0.11 85.0±2.3 
F5 83.75 8.5 73.28% 82.69±1.87 89.52±2.18 2.92±0.08 92.2±4.6 
 
* Mean ± SD, n=3 




Figure 3: Prepared hollow microspheres of DBM.  
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Drug content 
In case of drug content study, drug 
content for all the formulation was in the range 
of 82.69±1.87 - 96.1±1.40% w/v. 
 
Drug entrapment efficiency 
The amount of dextromethorphan 
hydrobromide present in the hollow 
microspheres was determined by extracting the 
drug into 0.1 N HCl under magnetic stirring for 
a period of 2h. The solution was filtered 
through Whatmann filter paper no.5, suitably 
diluted and estimated for drug content 
spectrophotometrically at 279 nm and tabulated 
in table III. Formulation F3 showed highest 
amount of entrapment efficiency of 
90.31±1.59% and this was one of the factor for 
determining the optimized formulation. 
 
Floating lag time 
All the batches of microspheres showed 
no lag time or a lag time of zero seconds which 
indicated that all the microspheres formed were 
hollow. 
 
Percentage of Mmoisture Loss 
Percentage of moisture loss of the for-
mulation was found in the range 1.63-3.97 %. 
 
In vitro buoyancy percentage 
In vitro buoyancy percentage was 
calculated as the ratio of the mass of the 
microspheres that remained floating and the 
total mass of the microspheres. The in vitro 
buoyancy percentage was calculated as per the 
procedure and tabulated. 
 
% Buoyancy = 
Microsphere remained floating 
X 100 
Total mass of microspheres 
 
In vitro release studies 
The in vitro release studies were 
performed in 250 ml of pH 1.2 HCl buffer 
thermostatically maintained at 37±0.5°C based 
on Chinese Pharmacopoeia (2005 Ed.) method 
II. Paddle rotational speed was set to 50rpm. 
10mL samples were withdrawn and replaced 
with an equal volume of the same fresh 
medium at predetermined time intervals. The 
sample solutions were filtered through a 0.45 
µm membrane and analyzed using a UV 
spectrophotometer at 279nm. Release pattern 
for formulation F1-F5 are shown in the 
following figure 4. 
Mathematical model fitting  
The in vitro release studies data was fitted 
into various mathematical models to determine 
which one is the best-fit model. The results 
indicated that the best-fit model of optimized 
formulation F3 was found to be peppas model 
while all other formulations were following first 
order. Graph between log percentage release 
and log time was plotted and n value was found 
to be 0.811 indicating the release of drug from 




The objective of stability studies is to 
predict the shelf life of a product by 
accelerating the rate of decomposition, 
preferably by increasing the temperature and 
RH. The optimized formulation (F-3) was 
subjected to stability studies according to ICH 
guidelines by storing at 25ºC/60 % RH and 
40ºC/75 % RH for 30days. These samples were 
analyzed and checked for changes in physical 
appearance and drug content at regular 
intervals. After analysis, drug content after 30 
days was found to be 98.66%0.82, after 60 
days it was 97.90%1.56 and after 90 days it 
was 97.55%±0.96. From the data, it was clear 
that the formulation did not undergo any 
chemical changes/interaction during the study 
period explained based on drug content values 
which was found to be significant. 
 
CONCLUSION 
The objective of this study was to 
prepare and evaluate floating hollow 
microspheres of Gelatin loaded with 
Dextromethorphan hydrobromide for 
controlled release. These microspheres were 
prepared by emulsion polymerization method. 
From the results, it can be concluded that the 
hollow microspheres formulation is easy to 
administer, simple with increased patient 
compliance. Formulation F3 was determined as 
the optimized formula as it exhibited highest 
drug entrapment efficiency and maximum drug 
release compared to other formulations. Hence 
dextromethorphan hydrobromide could be 
formulated into hollow microspheres as 
controlled drug release dosage form by 
emulsion polymerization method. 
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